Skip to main content
Erschienen in: Clinical Research in Cardiology 6/2012

01.06.2012 | Original Paper

Chronic protection against ischemia and reperfusion-induced endothelial dysfunction during therapy with different organic nitrates

verfasst von: Monica Lisi, Matthias Oelze, Saverio Dragoni, Andrew Liuni, Sebastian Steven, Mary-Clare Luca, Dirk Stalleicken, Thomas Münzel, Franco Laghi-Pasini, Andreas Daiber, John D. Parker, Tommaso Gori

Erschienen in: Clinical Research in Cardiology | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Ischemic and pharmacologic preconditioning have great clinical potential, but it remains unclear whether their effects can be maintained over time during repeated exposure.We have previously demonstrated that the acute protective effect of nitroglycerin (GTN) is attenuated during repeated daily administration. Pentaerythrityl tetranitrate (PETN) is an organic nitrate with different hemodynamic and biochemical properties. The purpose of the current experiment was to study the preconditioning-like effects of PETN and GTN during repeated daily exposure.

Methods and results

In a randomized, investigator-blind parallel trial, 30 healthy (age 25–32) volunteers were randomized to receive (1) transdermal GTN (0.6 mg/h) administered for 2 h a day for 6 days; (2) oral PETN (80 mg) once a day for 6 days; or (3) no therapy. One week later, endothelium-dependent flow-mediated dilation was assessed before and after exposure to ischemia and reperfusion (IR). IR caused a significant blunting of the endothelium-dependent relaxation in the control group (FMD before IR: 5.8 ± 2.1%; after IR 1.0 ± 2.1%; P < 0.01). Daily, 2-h exposure to GTN partially prevented IR-induced endothelial dysfunction (FMD before IR: 7.7 ± 2.4%; after IR 4.3 ± 3.0%; P < 0.01 compared to before IR). In contrast, daily PETN administration afforded greater protection from IR-induced endothelial injury (FMD before IR: 7.9 ± 1.7%; after IR 6.4 ± 5.3%, P = ns; P < 0.05 ANOVA across groups). In vitro, incubation of human endothelial cells with GTN (but not PETN) was associated with inhibition (P < 0.01) of aldehyde dehydrogenase, an enzyme that is important for both nitrate biotransformation and ischemic preconditioning.

Discussion

We previously showed that upon repeated administration, the preconditioning-like effects of GTN are attenuated. The present data demonstrate a gradient in the extent of protection afforded by the two nitrates, suggesting that PETN-induced preconditioning is maintained after prolonged administration in a human in vivo model of endothelial dysfunction induced by ischemia. Using isolated human endothelial cells, we propose a mechanistic explanation for this observation based on differential effects of GTN versus PETN on the activity of mitochondrial aldehyde dehydrogenase.
Literatur
2.
Zurück zum Zitat Bolli R, Dawn B, Tang XL, Qiu Y, Ping P, Xuan YT, Jones WK, Takano H, Guo Y, Zhang J (1998) The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol 93(5):325–338PubMedCrossRef Bolli R, Dawn B, Tang XL, Qiu Y, Ping P, Xuan YT, Jones WK, Takano H, Guo Y, Zhang J (1998) The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol 93(5):325–338PubMedCrossRef
3.
Zurück zum Zitat Szilvassy Z, Ferdinandy P, Nagy I, Jakab I, Koltai M (1997) The effect of continuous versus intermittent treatment with transdermal nitroglycerin on pacing-induced preconditioning in conscious rabbits. Br J Pharmacol 121(3):491–496. doi:10.1038/sj.bjp.0701163 PubMedCrossRef Szilvassy Z, Ferdinandy P, Nagy I, Jakab I, Koltai M (1997) The effect of continuous versus intermittent treatment with transdermal nitroglycerin on pacing-induced preconditioning in conscious rabbits. Br J Pharmacol 121(3):491–496. doi:10.​1038/​sj.​bjp.​0701163 PubMedCrossRef
4.
Zurück zum Zitat Leesar MA, Stoddard MF, Dawn B, Jasti VG, Masden R, Bolli R (2001) Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty. Circulation 103(24):2935–2941PubMed Leesar MA, Stoddard MF, Dawn B, Jasti VG, Masden R, Bolli R (2001) Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty. Circulation 103(24):2935–2941PubMed
5.
Zurück zum Zitat Crisafulli A, Melis F, Tocco F, Pittau G, Lorrai L, Gori T, Mancardi D, Concu A, Pagliaro P (2007) Delayed preconditioning-mimetic actions of exercise or nitroglycerin do not affect haemodynamics and exercise performance in trained or sedentary individuals. J Sports Sci 25(12):1393–1401. doi:10.1080/02640410601128914 PubMedCrossRef Crisafulli A, Melis F, Tocco F, Pittau G, Lorrai L, Gori T, Mancardi D, Concu A, Pagliaro P (2007) Delayed preconditioning-mimetic actions of exercise or nitroglycerin do not affect haemodynamics and exercise performance in trained or sedentary individuals. J Sports Sci 25(12):1393–1401. doi:10.​1080/​0264041060112891​4 PubMedCrossRef
7.
Zurück zum Zitat Dragoni S, Gori T, Lisi M, Di Stolfo G, Pautz A, Kleinert H, Parker JD (2007) Pentaerythrityl tetranitrate and nitroglycerin, but not isosorbide mononitrate, prevent endothelial dysfunction induced by ischemia and reperfusion. Arterioscler Thromb Vasc Biol 27(9):1955–1959. doi:10.1161/ATVBAHA.107.149278 PubMedCrossRef Dragoni S, Gori T, Lisi M, Di Stolfo G, Pautz A, Kleinert H, Parker JD (2007) Pentaerythrityl tetranitrate and nitroglycerin, but not isosorbide mononitrate, prevent endothelial dysfunction induced by ischemia and reperfusion. Arterioscler Thromb Vasc Biol 27(9):1955–1959. doi:10.​1161/​ATVBAHA.​107.​149278 PubMedCrossRef
8.
Zurück zum Zitat Gori T, Dragoni S, Di Stolfo G, Sicuro S, Liuni A, Luca MC, Thomas G, Oelze M, Daiber A, Parker JD (2010) Tolerance to nitroglycerin-induced preconditioning of the endothelium: a human in vivo study. Am J Physiol Heart Circ Physiol 298(2):H340–H345. doi:10.1152/ajpheart.01324.2008 PubMedCrossRef Gori T, Dragoni S, Di Stolfo G, Sicuro S, Liuni A, Luca MC, Thomas G, Oelze M, Daiber A, Parker JD (2010) Tolerance to nitroglycerin-induced preconditioning of the endothelium: a human in vivo study. Am J Physiol Heart Circ Physiol 298(2):H340–H345. doi:10.​1152/​ajpheart.​01324.​2008 PubMedCrossRef
10.
Zurück zum Zitat Schnorbus B, Schiewe R, Ostad MA, Medler C, Wachtlin D, Wenzel P, Daiber A, Munzel T, Warnholtz A (2010) Effects of pentaerythritol tetranitrate on endothelial function in coronary artery disease: results of the PENTA study. Clin Res Cardiol 99(2):115–124. doi:10.1007/s00392-009-0096-z PubMedCrossRef Schnorbus B, Schiewe R, Ostad MA, Medler C, Wachtlin D, Wenzel P, Daiber A, Munzel T, Warnholtz A (2010) Effects of pentaerythritol tetranitrate on endothelial function in coronary artery disease: results of the PENTA study. Clin Res Cardiol 99(2):115–124. doi:10.​1007/​s00392-009-0096-z PubMedCrossRef
11.
Zurück zum Zitat Jurt U, Gori T, Ravandi A, Babaei S, Zeman P, Parker JD (2001) Differential effects of pentaerythritol tetranitrate and nitroglycerin on the development of tolerance and evidence of lipid peroxidation: a human in vivo study. J Am Coll Cardiol 38(3):854–859PubMedCrossRef Jurt U, Gori T, Ravandi A, Babaei S, Zeman P, Parker JD (2001) Differential effects of pentaerythritol tetranitrate and nitroglycerin on the development of tolerance and evidence of lipid peroxidation: a human in vivo study. J Am Coll Cardiol 38(3):854–859PubMedCrossRef
13.
14.
15.
Zurück zum Zitat Edgell CJ, McDonald CC, Graham JB (1983) Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA 80(12):3734–3737PubMedCrossRef Edgell CJ, McDonald CC, Graham JB (1983) Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA 80(12):3734–3737PubMedCrossRef
16.
Zurück zum Zitat Wenzel P, Hink U, Oelze M, Seeling A, Isse T, Bruns K, Steinhoff L, Brandt M, Kleschyov AL, Schulz E, Lange K, Weiner H, Lehmann J, Lackner KJ, Kawamoto T, Munzel T, Daiber A (2007) Number of nitrate groups determines reactivity and potency of organic nitrates: a proof of concept study in ALDH-2−/− mice. Brit J Pharmacol 150:526–533CrossRef Wenzel P, Hink U, Oelze M, Seeling A, Isse T, Bruns K, Steinhoff L, Brandt M, Kleschyov AL, Schulz E, Lange K, Weiner H, Lehmann J, Lackner KJ, Kawamoto T, Munzel T, Daiber A (2007) Number of nitrate groups determines reactivity and potency of organic nitrates: a proof of concept study in ALDH-2−/− mice. Brit J Pharmacol 150:526–533CrossRef
17.
18.
Zurück zum Zitat Ostad MA, Nick E, Paixao-Gatinho V, Schnorbus B, Schiewe R, Tschentscher P, Munzel T, Warnholtz A (2010) Lack of evidence for pleiotropic effects of clopidogrel on endothelial function and inflammation in patients with stable coronary artery disease: results of the double-blind, randomized CASSANDRA study. Clin Res Cardiol 100(1):29–36. doi:10.1007/s00392-010-0199-6 PubMedCrossRef Ostad MA, Nick E, Paixao-Gatinho V, Schnorbus B, Schiewe R, Tschentscher P, Munzel T, Warnholtz A (2010) Lack of evidence for pleiotropic effects of clopidogrel on endothelial function and inflammation in patients with stable coronary artery disease: results of the double-blind, randomized CASSANDRA study. Clin Res Cardiol 100(1):29–36. doi:10.​1007/​s00392-010-0199-6 PubMedCrossRef
19.
Zurück zum Zitat Depre C, Park JY, Shen YT, Zhao X, Qiu H, Yan L, Tian B, Vatner SF, Vatner DE (2010) Molecular mechanisms mediating preconditioning following chronic ischemia differ from those in classical second window. Am J Physiol Heart Circ Physiol 299(3):H752–H762. doi:10.1152/ajpheart.00147.2010 Depre C, Park JY, Shen YT, Zhao X, Qiu H, Yan L, Tian B, Vatner SF, Vatner DE (2010) Molecular mechanisms mediating preconditioning following chronic ischemia differ from those in classical second window. Am J Physiol Heart Circ Physiol 299(3):H752–H762. doi:10.​1152/​ajpheart.​00147.​2010
20.
Zurück zum Zitat Shen YT, Depre C, Yan L, Park JY, Tian B, Jain K, Chen L, Zhang Y, Kudej RK, Zhao X, Sadoshima J, Vatner DE, Vatner SF (2008) Repetitive ischemia by coronary stenosis induces a novel window of ischemic preconditioning. Circulation 118(19):1961–1969. doi:10.1161/CIRCULATIONAHA.108.788240 PubMedCrossRef Shen YT, Depre C, Yan L, Park JY, Tian B, Jain K, Chen L, Zhang Y, Kudej RK, Zhao X, Sadoshima J, Vatner DE, Vatner SF (2008) Repetitive ischemia by coronary stenosis induces a novel window of ischemic preconditioning. Circulation 118(19):1961–1969. doi:10.​1161/​CIRCULATIONAHA.​108.​788240 PubMedCrossRef
21.
Zurück zum Zitat Griesberger M, Kollau A, Wolkart G, Wenzl MV, Beretta M, Russwurm M, Koesling D, Schmidt K, Gorren AC, Mayer B (2011) Bioactivation of pentaerythrityl tetranitrate by mitochondrial aldehyde dehydrogenase. Mol Pharmacol 79(3):541–548. doi:10.1124/mol.110.069138 PubMedCrossRef Griesberger M, Kollau A, Wolkart G, Wenzl MV, Beretta M, Russwurm M, Koesling D, Schmidt K, Gorren AC, Mayer B (2011) Bioactivation of pentaerythrityl tetranitrate by mitochondrial aldehyde dehydrogenase. Mol Pharmacol 79(3):541–548. doi:10.​1124/​mol.​110.​069138 PubMedCrossRef
25.
Zurück zum Zitat Hink U, Daiber A, Kayhan N, Trischler J, Kraatz C, Oelze M, Mollnau H, Wenzel P, Vahl CF, Ho KK, Weiner H, Munzel T (2007) Oxidative inhibition of the mitochondrial aldehyde dehydrogenase promotes nitroglycerin tolerance in human blood vessels. J Am Coll Cardiol 50(23):2226–2232. doi:10.1016/j.jacc.2007.08.031 PubMedCrossRef Hink U, Daiber A, Kayhan N, Trischler J, Kraatz C, Oelze M, Mollnau H, Wenzel P, Vahl CF, Ho KK, Weiner H, Munzel T (2007) Oxidative inhibition of the mitochondrial aldehyde dehydrogenase promotes nitroglycerin tolerance in human blood vessels. J Am Coll Cardiol 50(23):2226–2232. doi:10.​1016/​j.​jacc.​2007.​08.​031 PubMedCrossRef
26.
Zurück zum Zitat Szocs K, Lassegue B, Wenzel P, Wendt M, Daiber A, Oelze M, Meinertz T, Munzel T, Baldus S (2007) Increased superoxide production in nitrate tolerance is associated with NAD(P)H oxidase and aldehyde dehydrogenase 2 downregulation. J Mol Cell Cardiol 42(6):1111–1118. doi:10.1016/j.yjmcc.2007.03.904 PubMedCrossRef Szocs K, Lassegue B, Wenzel P, Wendt M, Daiber A, Oelze M, Meinertz T, Munzel T, Baldus S (2007) Increased superoxide production in nitrate tolerance is associated with NAD(P)H oxidase and aldehyde dehydrogenase 2 downregulation. J Mol Cell Cardiol 42(6):1111–1118. doi:10.​1016/​j.​yjmcc.​2007.​03.​904 PubMedCrossRef
27.
Zurück zum Zitat Chen Z, Foster MW, Zhang J, Mao L, Rockman HA, Kawamoto T, Kitagawa K, Nakayama KI, Hess DT, Stamler JS (2005) An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation. Proc Natl Acad Sci USA 102(34):12159–12164PubMedCrossRef Chen Z, Foster MW, Zhang J, Mao L, Rockman HA, Kawamoto T, Kitagawa K, Nakayama KI, Hess DT, Stamler JS (2005) An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation. Proc Natl Acad Sci USA 102(34):12159–12164PubMedCrossRef
28.
Zurück zum Zitat Ciccone MM, Iacoviello M, Puzzovivo A, Scicchitano P, Monitillo F, De Crescenzo F, Caragnano V, Sassara M, Quistelli G, Guida P, Favale S (2011) Clinical correlates of endothelial function in chronic heart failure. Clin Res Cardiol 100(6):515–521. doi:10.1007/s00392-010-0275-y PubMedCrossRef Ciccone MM, Iacoviello M, Puzzovivo A, Scicchitano P, Monitillo F, De Crescenzo F, Caragnano V, Sassara M, Quistelli G, Guida P, Favale S (2011) Clinical correlates of endothelial function in chronic heart failure. Clin Res Cardiol 100(6):515–521. doi:10.​1007/​s00392-010-0275-y PubMedCrossRef
29.
Zurück zum Zitat Trojnarska O, Szczepaniak-Chichel L, Mizia-Stec K, Gabriel M, Bartczak A, Grajek S, Gasior Z, Kramer L, Tykarski A (2011) Vascular remodeling in adults after coarctation repair: impact of descending aorta stenosis and age at surgery. Clin Res Cardiol 100(5):447–455. doi:10.1007/s00392-010-0263-2 PubMedCrossRef Trojnarska O, Szczepaniak-Chichel L, Mizia-Stec K, Gabriel M, Bartczak A, Grajek S, Gasior Z, Kramer L, Tykarski A (2011) Vascular remodeling in adults after coarctation repair: impact of descending aorta stenosis and age at surgery. Clin Res Cardiol 100(5):447–455. doi:10.​1007/​s00392-010-0263-2 PubMedCrossRef
30.
Zurück zum Zitat Zankl AR, Ivandic B, Andrassy M, Volz HC, Krumsdorf U, Blessing E, Katus HA, Tiefenbacher CP (2010) Telmisartan improves absolute walking distance and endothelial function in patients with peripheral artery disease. Clin Res Cardiol 99(12):787–794. doi:10.1007/s00392-010-0184-0 PubMedCrossRef Zankl AR, Ivandic B, Andrassy M, Volz HC, Krumsdorf U, Blessing E, Katus HA, Tiefenbacher CP (2010) Telmisartan improves absolute walking distance and endothelial function in patients with peripheral artery disease. Clin Res Cardiol 99(12):787–794. doi:10.​1007/​s00392-010-0184-0 PubMedCrossRef
31.
Zurück zum Zitat Bulut D, Scheeler M, Niedballa LM, Miebach T, Mugge A (2011) Effects of immunoadsorption on endothelial function, circulating endothelial progenitor cells and circulating microparticles in patients with inflammatory dilated cardiomyopathy. Clin Res Cardiol 100(7):603–610. doi:10.1007/s00392-011-0287-2 PubMedCrossRef Bulut D, Scheeler M, Niedballa LM, Miebach T, Mugge A (2011) Effects of immunoadsorption on endothelial function, circulating endothelial progenitor cells and circulating microparticles in patients with inflammatory dilated cardiomyopathy. Clin Res Cardiol 100(7):603–610. doi:10.​1007/​s00392-011-0287-2 PubMedCrossRef
32.
Zurück zum Zitat Karthikeyan VJ, Blann AD, Baghdadi S, Lane DA, Gareth Beevers D, Lip GY (2011) Endothelial dysfunction in hypertension in pregnancy: associations between circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factor. Clin Res Cardiol 100(6):531–537. doi:10.1007/s00392-010-0277-9 PubMedCrossRef Karthikeyan VJ, Blann AD, Baghdadi S, Lane DA, Gareth Beevers D, Lip GY (2011) Endothelial dysfunction in hypertension in pregnancy: associations between circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factor. Clin Res Cardiol 100(6):531–537. doi:10.​1007/​s00392-010-0277-9 PubMedCrossRef
33.
Zurück zum Zitat Czucz J, Cervenak L, Forhecz Z, Gombos T, Pozsonyi Z, Kunde J, Karadi I, Janoskuti L, Prohaszka Z (2011) Serum soluble E-selectin and NT-proBNP levels additively predict mortality in diabetic patients with chronic heart failure. Clin Res Cardiol 100(7):587–594. doi:10.1007/s00392-011-0283-6 PubMedCrossRef Czucz J, Cervenak L, Forhecz Z, Gombos T, Pozsonyi Z, Kunde J, Karadi I, Janoskuti L, Prohaszka Z (2011) Serum soluble E-selectin and NT-proBNP levels additively predict mortality in diabetic patients with chronic heart failure. Clin Res Cardiol 100(7):587–594. doi:10.​1007/​s00392-011-0283-6 PubMedCrossRef
34.
Zurück zum Zitat Wenzel P, Schulz E, Gori T, Ostad MA, Mathner F, Schildknecht S, Gobel S, Oelze M, Stalleicken D, Warnholtz A, Munzel T, Daiber A (2009) Monitoring white blood cell mitochondrial aldehyde dehydrogenase activity: implications for nitrate therapy in humans. J Pharmacol Exp Ther 330(1):63–71. doi:10.1124/jpet.108.149716 PubMedCrossRef Wenzel P, Schulz E, Gori T, Ostad MA, Mathner F, Schildknecht S, Gobel S, Oelze M, Stalleicken D, Warnholtz A, Munzel T, Daiber A (2009) Monitoring white blood cell mitochondrial aldehyde dehydrogenase activity: implications for nitrate therapy in humans. J Pharmacol Exp Ther 330(1):63–71. doi:10.​1124/​jpet.​108.​149716 PubMedCrossRef
35.
Zurück zum Zitat Weber W, Michaelis K, Luckow V, Kuntze U, Stalleicken D (1995) Pharmacokinetics and bioavailability of pentaerithrityl tetranitrate and two of its metabolites. Arzneimittelforschung 45(7):781–784PubMed Weber W, Michaelis K, Luckow V, Kuntze U, Stalleicken D (1995) Pharmacokinetics and bioavailability of pentaerithrityl tetranitrate and two of its metabolites. Arzneimittelforschung 45(7):781–784PubMed
36.
Zurück zum Zitat Kanamasa K, Naito N, Morii H, Nakano K, Tanaka Y, Kitayama K, Haku R, Kai T, Yonekawa O, Nagatani Y, Ishikawa K (2004) Eccentric dosing of nitrates does not increase cardiac events in patients with healed myocardial infarction. Hypertens Res 27(8):563–572 (pii:JST.JSTAGE/hypres/27.563)PubMedCrossRef Kanamasa K, Naito N, Morii H, Nakano K, Tanaka Y, Kitayama K, Haku R, Kai T, Yonekawa O, Nagatani Y, Ishikawa K (2004) Eccentric dosing of nitrates does not increase cardiac events in patients with healed myocardial infarction. Hypertens Res 27(8):563–572 (pii:JST.JSTAGE/hypres/27.563)PubMedCrossRef
37.
Zurück zum Zitat Poss J, Jacobshagen C, Ukena C, Bohm M (2011) Hotlines and clinical trial updates presented at the German Cardiac Society Meeting 2010: FAIR-HF, CIPAMI, LIPSIA-NSTEMI, Handheld-BNP, PEPCAD III, remote ischaemic conditioning, CERTIFY, PreSCD-II, German Myocardial Infarction Registry, DiaRegis. Clin Res Cardiol 99(7):411–417. doi:10.1007/s00392-010-0176-0 CrossRef Poss J, Jacobshagen C, Ukena C, Bohm M (2011) Hotlines and clinical trial updates presented at the German Cardiac Society Meeting 2010: FAIR-HF, CIPAMI, LIPSIA-NSTEMI, Handheld-BNP, PEPCAD III, remote ischaemic conditioning, CERTIFY, PreSCD-II, German Myocardial Infarction Registry, DiaRegis. Clin Res Cardiol 99(7):411–417. doi:10.​1007/​s00392-010-0176-0 CrossRef
Metadaten
Titel
Chronic protection against ischemia and reperfusion-induced endothelial dysfunction during therapy with different organic nitrates
verfasst von
Monica Lisi
Matthias Oelze
Saverio Dragoni
Andrew Liuni
Sebastian Steven
Mary-Clare Luca
Dirk Stalleicken
Thomas Münzel
Franco Laghi-Pasini
Andreas Daiber
John D. Parker
Tommaso Gori
Publikationsdatum
01.06.2012
Verlag
Springer-Verlag
Erschienen in
Clinical Research in Cardiology / Ausgabe 6/2012
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-012-0412-x

Weitere Artikel der Ausgabe 6/2012

Clinical Research in Cardiology 6/2012 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.